Dr. Lukas Burkhardt is Gerresheimer’s new member of the management board
Gerresheimer has elected a new member of its management board for the Primary Packaging Glass Division.
Dr. Lukas Burkhardt (38) has been appointed to the Management Board of Gerresheimer AG effective 1 January 2018. Lukas Burkhardt assumes responsibility on the Gerresheimer Management Board for the Primary Packaging Glass Division.
“In Lukas Burkhardt, we gain an outstanding leadership personality as a valuable addition to the Gerresheimer AG Management Board. He will be able to contribute his diverse international experience from a variety of industries very well to the Primary Packaging Glass Division,” said Dr. Axel Herberg, Chairman of the Gerresheimer AG Supervisory Board.
Lukas Burkhardt studied mechanical engineering at ETH Zurich, where he also obtained his PhD. He began his career at Audi AG in Ingolstadt. From 2007 to 2014, he held various managerial positions within the Rieter Automotive Group, now the Autoneum Group, including six years in China and India. Most recently, he was in charge of all Asian plants as Head of Operations Asia. In 2015, he became Chief Operating Officer and member of the Group Management Board of the international Franke Group. There, he was responsible for production at more than 30 plants worldwide as well as for logistics, procurement, and process engineering and partly product engineering.
The Management Board of Gerresheimer AG now comprises Christian Fischer (CEO), Rainer Beaujean (CFO), Andreas Schütte (Plastics and Devices Division) and Lukas Burkhardt (Primary Packaging Glass Division).
Gerresheimer is a leading global partner to the pharma and healthcare industries. The company’s special glass and plastic products contribute to health and well-being. Gerresheimer is a global organization with about 10,000 employees and manufacturing operations in the local markets, close to customers. With plants in Europe, North and South America and Asia Gerresheimer generates revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging products as well as convenient and safe drug delivery systems such as insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products.